| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Ko-143 | CTRPv2 | pan-cancer | AAC | 0.027 | 0.5 |
| mRNA | BRD9876 | CTRPv2 | pan-cancer | AAC | 0.028 | 0.5 |
| mRNA | pac-1 | CTRPv2 | pan-cancer | AAC | 0.026 | 0.5 |
| mRNA | piperlongumine | CTRPv2 | pan-cancer | AAC | 0.023 | 0.5 |
| mRNA | momelotinib | CTRPv2 | pan-cancer | AAC | 0.025 | 0.5 |
| mRNA | Doxorubicin | CTRPv2 | pan-cancer | AAC | 0.021 | 0.5 |
| mRNA | Crizotinib | gCSI | pan-cancer | AAC | -0.04 | 0.5 |
| mRNA | tivozanib | CTRPv2 | pan-cancer | AAC | -0.026 | 0.5 |
| mRNA | BRD-K41334119 | CTRPv2 | pan-cancer | AAC | 0.052 | 0.5 |
| mRNA | hyperforin | CTRPv2 | pan-cancer | AAC | 0.027 | 0.5 |